Reconstituting Immunity Post Transplant

H6676: Administration of EBV specific Cytotoxic T Lymphocytes to Recipients of Mismatched-related or Phenotypically Similar Unrelated Donor Marrow Grafts: This study uses allogeneic EBV specific T-Lymphocytes to prevent or treat EBV related infection following an allogeneic stem cell transplant.

H12683: Virus Specific Cytotoxic T-Lymphocytes for the Prophylaxis of CMB after  Allogeneic Stem Cell Transplant: A Dose-Finding Trial: This study uses allogeneic CMV specific T-Lymphocytes to prevent CMV related infection following an allogeneic stem cell transplant.

H22994: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lyphocytes (CTL) to treat Persistent Reactivation or Infection with Adenovirus, CMV and EBV after Hemopoietic Stem Cell Transplantation (SCCT Protocol): This study uses allogeneic Epstein Barr virus (EBV), cytomegalovirus (CMV) and adenovirus (AdV) T cells to treat persistent viral infections following an allogeneic Stem Cell Transplant. The cells will be obtained from a donor that is a partial match with the patient and the transplant donor.

H23668: Adoptive transfer of Cord blood T cells to prevent and treat  CMV and Adenovirus infections after Transplantation: This study uses cytomegalovirus (CMV) and adenovirus (AdV) T cells to treat AdV and/or CMV infection following a cord blood transplant.

©2002, Cell And Gene Therapy, Baylor College of Medicine
One Baylor Plaza, N1002, Houston, TX 77030, (713)798-1246
URL: http://www.bcm.edu/genetherapy Email:cagt@bcm.edu
(Modified: September 21st, 2007 - jb)